All In Biotech

Free tool

FAERS Monitor: Rayaldee

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208010 or its brand name (Rayaldee, Calcifediol). Reports on generic versions are filed under their own applications.

Reports

2,547

Serious

2,435

96% of reports

Hospitalization

1,307

Death reported

384

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death219
  • off label use141
  • drug interaction131
  • acute kidney injury127
  • anaemia78
  • nausea76
  • dyspnoea74
  • pneumonia70
  • pyrexia70
  • covid-1964
  • hypotension63
  • diarrhoea62
  • vomiting60
  • drug ineffective59
  • somnolence59

Reports by year received

View as table
YearReports
20046
20053
20063
20071
20083
20095
201012
20112
201210
20137
20149
201511
201615
201740
201879
2019122
2020158
2021166
2022267
2023392
2024494
2025358
2026384

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,612 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal1276.95.8634
drug interactionSignal1316.85.8650
anaemiaSignal783.42.7129
covid-19Signal643.02.485
hypotensionSignal632.62.061
somnolenceSignal592.41.948
deathSignal2192.11.8130
pneumonia701.81.424
pyrexia701.71.318
off label use1411.31.112
dyspnoea741.10.90
vomiting601.10.80
diarrhoea620.80.63
nausea760.80.64
drug ineffective590.40.367

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.